Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "DE Frankfurt Schmoll D"

From Bioblast
 
(7 intermediate revisions by 4 users not shown)
Line 1: Line 1:
{{MiPNetLab
{{O2k-Network Lab
|institution=Sanofi-Aventis Deutschland GmbH
|institution=Sanofi-Aventis Deutschland GmbH


Line 9: Line 9:
|city=Frankfurt
|city=Frankfurt
|country=Germany
|country=Germany
|Contact=Schmoll D
|Contact=Schmoll Dieter
|MiPNetLab=Fischer S, Schlotte V
|MiPNetLab=Fischer Silvia
|Status=O2k 2009-
|Status=O2k 2009-
|keywords=
|info=[[IOC88]], [[IOC75]], [[IOC60]], [[IOC54]]
}}
}}
== Power-O2k ==
== Power-O2k ==
* [[DE Frankfurt Sanofi]]
::::* [[DE Frankfurt Sanofi]]

Latest revision as of 15:36, 21 March 2019

                



DE Frankfurt Schmoll D

Oroboros O2k-Network

O2k-Network
O2k-Network Lab Sanofi-Aventis Deutschland GmbH

R&D TD Metabolism FFM

Address Industriepark Hoechst

Bldg. H825, Room 243, 65926

City Frankfurt
State/Prov
Country Germany
Weblink
Contact Schmoll Dieter
Team Fischer Silvia
Team previous
Status O2k 2009-
Oroboros Events IOC88, IOC75, IOC60, IOC54
Topics


O2k-Publications

 PublishedReference
Karusheva 2019 Am J Clin Nutr2019Karusheva Y, Koessler T, Strassburger K, Markgraf D, Mastrototaro L, Jelenik T, Simon MC, Pesta D, Zaharia OP, Bódis K, Bärenz F, Schmoll D, Wolkersdorfer M, Tura A, Pacini G, Burkart V, Müssig K, Szendroedi J, Roden M (2019) Short-term dietary reduction of branched-chain amino acids reduces meal-induced insulin secretion and modifies microbiome composition in type 2 diabetes: a randomized controlled crossover trial. Am J Clin Nutr 110:1098-107.

O2k-Abstracts

update please

Power-O2k